Results 161 to 170 of about 4,546 (178)

Targeting of the m<sup>6</sup>A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer. [PDF]

open access: yesNat Commun
Zhou H   +17 more
europepmc   +1 more source

METTL3 safeguards cell identity and epigenome of human trophoblast stem cells. [PDF]

open access: yesNat Commun
Fu H   +20 more
europepmc   +1 more source

YTHDC2 suppresses bladder cancer by inhibiting SOX2-mediated tumor plasticity. [PDF]

open access: yesCell Death Dis
Cai Y   +10 more
europepmc   +1 more source

FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE. [PDF]

open access: yesClin Exp Med
Zhang J   +8 more
europepmc   +1 more source

M<sup>6</sup>A modification mediates CACNA1A stability to drive the progression of ovarian cancer by inhibiting ferroptosis. [PDF]

open access: yesJ Ovarian Res
Gong X   +12 more
europepmc   +1 more source

Global mapping of RNA N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) in human subcutaneous and visceral adipose tissue reveals novel targets that correlate with clinical variables of obesity. [PDF]

open access: yesBiomark Res
Rønningen T   +17 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

MeTDiff: A Novel Differential RNA Methylation Analysis for MeRIP-Seq Data

IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2018
N6-Methyladenosine (m6A) transcriptome methylation is an exciting new research area that just captures the attention of research community. We present in this paper, MeTDiff, a novel computational tool for predicting differential m6A methylation sites from Methylated RNA immunoprecipitation sequencing (MeRIP-Seq) data.
Xiaodong, Cui   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy